Increased in vivo immunological potency of HB-110, a novel therapeutic HBV DNA vaccine, by electroporation

• Published in: Experimental & molecular medicine Vol. 40; no. 6; pp. 669 - 676
• Main Authors: Kim, Chae Young, Kang, Eun Sung, Kim, Seon Beom, Kim, Han Eol, Choi, Jae Hoon, Lee, Dong Sop, Im, Se Jin, Yang, Se Hwan, Sung, Young Chul, Kim, Byong Moon, Kim, Byung-Gee
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 31.12.2008; Springer Nature B.V; Korean Society of Medical Biochemistry and Molecular Biology; 생화학분자생물학회
• Subjects: Animals; Biomedical and Life Sciences; Biomedicine; Electroporation; Hepatitis B Antigens - biosynthesis; Hepatitis B Vaccines - administration & dosage; Hepatitis B Vaccines - immunology; Hepatitis B virus; Hepatitis B, Chronic - immunology; Hepatitis B, Chronic - prevention & control; Immunity, Cellular; Male; Medical Biochemistry; Mice; Mice, Inbred BALB C; Molecular Medicine; Original; Stem Cells; Vaccines, DNA - administration & dosage; Vaccines, DNA - immunology; 생화학; vaccines, DNA; electroporation; hepatitis B virus; vaccination
• ISSN: 1226-3613; 2092-6413
• DOI: 10.3858/emm.2008.40.6.669

Pulse-induced permeabilization of cellular membranes, generally referred to as electroporation (EP), has been used for years as a tool to increase macromolecule uptake in tissues, including nucleic acids, for gene therapeutic applications, and this technique has been shown to result in improved immunogenicity. In this study, we assessed the utility of EP as a tool to improve the efficacy of HB-110, a novel therapeutic DNA vaccine against chronic hepatitis B, now in phase 1 of clinical study in South Korea. The potency of HB-110 in mice was shown to be improved by EP. The rapid onset of antigen expression and higher magnitude of humoral and cellular responses in electric pulse-treated mice revealed that EP may enable a substantial reduction in the dosage of DNA vaccine required to elicit a response similar in magnitude to that achievable via conventional administration. This study also showed that EP-based vaccination at 4-week-intervals elicited a cellular immune response which was about two-fold higher than the response elicited by conventional vaccination at 2-week intervals. These results may provide a rationale to reduce the clinical dose and increase the interval between the doses in the multidose vaccination schedule. Electric pulsing also elicited a more balanced immune response against four antigens expressed by HB-110: S, preS, Core, and Pol.